201 related articles for article (PubMed ID: 35342356)
1. Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.
Kong Y; Ren W; Fang H; Shah NA; Shi Y; You D; Zhou C; Jiang D; Yang C; Liang H; Liu W; Wang L; Gan W; Wan X; Li F; Li Z; Chen C; Xie N
Int J Biol Sci; 2022; 18(5):2104-2115. PubMed ID: 35342356
[TBL] [Abstract][Full Text] [Related]
2. HDAC-mediated deacetylation of KLF5 associates with its proteasomal degradation.
Tao R; Zhang B; Li Y; King JL; Tian R; Xia S; Schiavon CR; Dong JT
Biochem Biophys Res Commun; 2018 Jun; 500(3):777-782. PubMed ID: 29679567
[TBL] [Abstract][Full Text] [Related]
3. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
4. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
[TBL] [Abstract][Full Text] [Related]
5. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
Shin J; Carr A; Corner GA; Tögel L; Dávalos-Salas M; Tran H; Chueh AC; Al-Obaidi S; Chionh F; Ahmed N; Buchanan DD; Young JP; Malo MS; Hodin RA; Arango D; Sieber OM; Augenlicht LH; Dhillon AS; Weber TK; Mariadason JM
J Biol Chem; 2014 Sep; 289(36):25306-16. PubMed ID: 25037223
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
Qiu X; Rong X; Yang J; Lu Y
BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
[TBL] [Abstract][Full Text] [Related]
7. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Jiang D; Qiu T; Peng J; Li S; Tala ; Ren W; Yang C; Wen Y; Chen CH; Sun J; Wu Y; Liu R; Zhou J; Wu K; Liu W; Mao X; Zhou Z; Chen C
Cell Death Differ; 2022 Jun; 29(6):1283-1295. PubMed ID: 35022570
[TBL] [Abstract][Full Text] [Related]
8. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
10. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
[TBL] [Abstract][Full Text] [Related]
11. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
[TBL] [Abstract][Full Text] [Related]
12. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
[TBL] [Abstract][Full Text] [Related]
13. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
Yang PM; Lin PJ; Chen CC
Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
[TBL] [Abstract][Full Text] [Related]
14. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
Chikamatsu K; Ishii H; Murata T; Sakakura K; Shino M; Toyoda M; Takahashi K; Masuyama K
Cancer Sci; 2013 Nov; 104(11):1468-75. PubMed ID: 23992541
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
Mateen S; Raina K; Jain AK; Agarwal C; Chan D; Agarwal R
Epigenetics; 2012 Oct; 7(10):1161-72. PubMed ID: 22965008
[TBL] [Abstract][Full Text] [Related]
16. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
[TBL] [Abstract][Full Text] [Related]
18. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
Chen CH; Yang N; Zhang Y; Ding J; Zhang W; Liu R; Liu W; Chen C
Int J Biol Sci; 2019; 15(8):1733-1742. PubMed ID: 31360115
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors impair the host immune response against Mycobacterium tuberculosis infection.
Zhu C; Cai Y; Zhu J; Zhang L; Xing A; Pan L; Jia H; Mo S; Feng CG; Shen H; Chen X; Zhang Z
Tuberculosis (Edinb); 2019 Sep; 118():101861. PubMed ID: 31526947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
